Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FZCN8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,472
Award facts
- Contract value 100% obligated
- $3,471.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,471.55 by the Defense Logistics Agency on May 30, 2025, for the supply of Nexplanon 68 mg implants. The award was issued under a firm fixed-price contract type with no set-aside designation, with an ultimate completion date of June 23, 2025. This delivery order represents a discrete procurement action leveraging DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA under the SPE2DB program.
DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, holding a substantial single-award IDC valued at $499,999,999 and valid through November 2026. This master contract enables DLA to issue firm fixed-price delivery orders for an extensive portfolio of pharmaceutical products supporting medical supply requirements at military healthcare facilities worldwide. The company's federal contracting history demonstrates consistent success in delivering prescription medications, biologics, medical devices, and pharmaceutical consumables to Department of Defense healthcare sites, establishing the firm as a reliable vendor for specialized pharmaceutical products including contraceptive devices, oncology treatments, and other medical supplies essential to military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FZCN8?
SPE2DB25FZCN8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on May 30, 2025.
How much is contract SPE2DB25FZCN8 worth?
The government has obligated $3,472 on SPE2DB25FZCN8.
Is contract SPE2DB25FZCN8 an order under another contract?
Yes. SPE2DB25FZCN8 is a delivery order under SPE2DB24D9134, an indefinite delivery contract.
Was contract SPE2DB25FZCN8 competed?
The extent of competition for SPE2DB25FZCN8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award